Does Otrexup Hurt Less Than Methotrexate Vials?
Yes, Otrexup, an autoinjector for methotrexate, causes less injection pain than traditional methotrexate vials with syringes. A 2015 study of 149 rheumatoid arthritis patients found Otrexup users reported significantly lower pain scores—median 3 mm on a 100 mm visual analog scale versus 17 mm for vial-and-syringe users (p<0.001).[1] Patients preferred Otrexup for its ease and reduced discomfort, with 93% favoring it over vials.
Why the Pain Difference?
Vials require manual drawing, syringe filling, and deeper needle insertion, often leading to higher pain from air bubbles or inconsistent technique. Otrexup's single-use device auto-injects subcutaneously with a 29-gauge needle, minimizing depth and pressure. It also hides the needle, reducing anxiety-related pain.[1][2]
What Do Real Patients Say?
User reviews on forums like Reddit and Drugs.com echo this: many describe vial injections as "burning" or "stinging," while Otrexup feels like "a quick pinch." Some still note mild soreness at the site, but far less than vials. A subset reports no difference if technique is poor.[3]
How Does Dosing Compare?
Otrexup delivers 7.5–25 mg weekly doses identically to vials, but its fixed volumes (0.4–0.8 mL) suit subcutaneous use better than vials' variable concentrations. No efficacy difference, but Otrexup avoids oral methotrexate's GI side effects.[2][4]
Cost and Availability
Otrexup costs $500–$1,000 monthly without insurance (vs. $20–$50 for generic vials), though copay cards lower it to $5–$25. It's prescription-only; vials are cheaper but require pharmacy compounding.[4]
Side Effects Beyond Pain
Both share methotrexate risks like nausea, fatigue, and liver issues, but Otrexup may reduce injection-site reactions (3% vs. 10–20% with vials).[2] Monitor bloodwork regardless.
[1]: Rheumatology study on Otrexup pain (PubMed)
[2]: Otrexup prescribing info (FDA)
[3]: Patient reviews (Drugs.com)
[4]: GoodRx pricing comparison